Breaking News Instant updates and real-time market news.

SRCI

SRC Energy

, ZYNE

Zynerba

$6.19

0.35 (5.99%)

09:40
09/28/17
09/28
09:40
09/28/17
09:40

Unusually active option classes on open September 28th

Unusual total active option classes on open include: SRC Energy (SRCI), Zynerba (ZYNE), Alaska Air (ALK), Widsomtree Japan (DXJ), ProShares UltraShort Lehman 20 plus Year Treasury (TBT), BlackBerry (BBRY), Weatherford (WFT), Market Vectors Oil Services (OIH), Wells Fargo (WFC), and Transocean (RIG).

SRCI

SRC Energy

ZYNE

Zynerba

$6.19

0.35 (5.99%)

ALK

Alaska Air

DXJ

WisdomTree Japan Hedged Equity Fund

TBT

ProShares UltraShort 20+ yr Trsry

BBRY

BlackBerry

$9.23

0.09 (0.98%)

WFT

Weatherford

OIH

Oil Services Holders Trust

WFC

Wells Fargo

RIG

Transocean

  • 28

    Sep

  • 28

    Sep

  • 02

    Oct

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 01

    Nov

  • 29

    Nov

  • 15

    Jan

  • 16

    May

SRCI SRC Energy

09/28/17
IMPC
09/28/17
INITIATION
Target $11
IMPC
Outperform
SRC Energy initiated with an Outperform at Imperial Capital
Imperial Capital analyst Irene Haas started SRC Energy with an Outperform rating and $11 price target.
05/03/17
WELS
05/03/17
DOWNGRADE
WELS
Market Perform
SRC Energy downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst David Tameron downgraded SRC Energy to Market Perform saying the preliminary findings regarding the tragic situation in Firestone, Colorado will be an overhang on the Denver-Julesburg Basin players. All DJ basin-exposed names will remain under pressure given the fear of a potential regulatory response, Tameron tells investors in a research note. The analyst lowered his price target range for the shares to $6-$9 from $11-$13.
05/03/17
WELS
05/03/17
DOWNGRADE
WELS
Market Perform
Extraction downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst David Tameron downgraded Extraction Oil & Gas (XOG) to Market Perform saying the preliminary findings regarding the tragic situation in Firestone, Colorado will be an overhang on the Denver-Julesburg Basin players. All DJ basin-exposed names will remain under pressure given the fear of a potential regulatory response, Tameron tells investors in a research note. The analyst lowered his price target range for the shares to $14-$17 from $20-$23. Tameron this morning also downgraded Anadarko (APC) and SRC Energy (SRCI) to Market Perform. He notes that Market Perform-rated Noble Energy (NBL) and PDC Energy (PDCE) also have meaningful DJ basin exposure.
06/21/17
GHSC
06/21/17
DOWNGRADE
GHSC
Neutral
SRC Energy downgraded to Neutral from Buy at Seaport Global
ZYNE Zynerba
$6.19

0.35 (5.99%)

08/15/17
08/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Overweight from Neutral at Cantor with analyst Kip Paulson saying he believes the risk/reward has shifted significantly following yesterday's expiration of the largest remaining lock-up period and the 8.5% share decline since Snap's second quarter earnings report. 2. GoPro (GPRO) upgraded to Neutral from Sell at Goldman Sachs with analyst Doug Clark saying GoPro is on track to launch a new HERO6 camera in the second half of 2017, and product launches have historically been a positive catalyst for the stock. 3. NetApp (NTAP) upgraded to Buy from Neutral at Longbow with analyst Joe Wittine citing a survey which showed that the company's share gains have continued. 4. American Eagle (AEO) upgraded to Buy from Neutral at FBR Capital with analyst Susan Anderson saying the valuation "has become very attractive." 5. Zynerba (ZYNE) upgraded to Buy from Neutral at Roth Capital with analyst Michael Higgins saying he was not bullish on yesterday's failed ZYN002 in osteoarthritis study. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/17
ROTH
08/15/17
UPGRADE
Target $15
ROTH
Buy
Zynerba upgraded to Buy post study failure selloff at Roth Capital
Roth Capital analyst Michael Higgins upgraded Zynerba Pharmaceuticals to Buy from Neutral with a $15 price target. Both Oppenheimer and Jefferies downgraded the stock this morning. The analyst says he was not bullish on yesterday's failed ZYN002 in osteoarthritis study. He views the corresponding selloff as a buying opportunity ahead of ZYN002's data in 20 children with Fragile X Syndrome, which is due in September. Unlike the fixed dosing regimens of the previous two trials, the dose regimen in the FAB-C trial will be beneficial to the trial's outcome, Higgins tells investors in a research note.
08/15/17
08/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) downgraded to Neutral from Buy at BofA/Merrill with analyst Ross Gilardi saying he is cautious into the print given recent data and expects the pace of earnings performance relative to expectations to begin to subside. 2. Zynerba (ZYNE) was downgraded to Perform from Outperform at Oppenheimer and to Hold from Buy at Jefferies. 3. Uniti Group (UNIT) downgraded to Neutral from Buy at BofA/Merrill with analyst David Barden saying Windstream's (WIN) dividend cut increases concerns about the health of the business and, combined with Uniti's increasing cost of capital, creates a negative feedback loop for the stock. 4. Farmland Partners (FPI) downgraded to Neutral from Outperform at Baird with the firm's analyst saying financial leverage is moving towards 18x EBITDA following the recent preferred offering, and the participating rights could create a liability for the common holders that could grow over time and a common dividend AFFO payout ratio over 130% estimated through YE19. 5. Banco Santander (SAN) downgraded to Neutral from Buy at Goldman Sachs with analyst Jose Abad seeing the valuation as full following the recent outperformance of the shares. The analyst lowered his price target for the shares to EUR 6.40. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/21/17
ADAM
08/21/17
NO CHANGE
Target $9
ADAM
Buy
Zynerba price target lowered to $9 from $35 at Canaccord
Canaccord analyst Arinda Lee lowered her price target on Zynerba to $9 from $35 following its announcement of two failed Phase 2 cannabidiol drug trials. The analyst is still not removing epilepsy and osteoarthritis from her valuation, pending clarity on regulatory pathways. Lee maintained her Buy rating on Zynerba shares.
ALK Alaska Air

06/29/17
BOFA
06/29/17
NO CHANGE
BOFA
BofA/Merrill raises Airline estimates, Delta and Southwest best positioned
BofA/Merrill analyst Andrew Didora raised Airline estimates and price target to reflect lower fuel pricing and remains positive on the industry said to remain selective into second-half 2017. The analyst believes Buy rated Delta Air Lines (DAL) and Southwest (LUV) are best positioned for sequential unit revenue improvement in the second half due to decelerating and easing comps and raised their price targets to $71 and $75 from $64 and $62, respectively. The analyst expects capacity to increase modestly in 2018 to +3.4% from +2.8% in 2017 and expects Delta to accelerate capacity growth to +1.9% and Southwest to +5%. As part of the sector note, Didora raised Buy rated United Continental's (UAL) price target to $105 from $85, Alaska Air's (ALK) to $120 from $115, Spirit Airlines' (SAVE) down to $68 from $75, and raised Underperform rated American Airlines' (AAL) to $42 from $40 and lowered Hawaiian Holdings' (AAL) to $43 from $47.
07/10/17
OPCO
07/10/17
NO CHANGE
OPCO
Oppenheimer recommends buying American Airlines, United Continental
Oppenheimer analyst Ari Wald continues to make the case that interest rates are bottoming, reflationary sectors are positioned for a stronger second half, and market internals should strengthen as well. The analyst sees additional upside for both Banks and Transports, and within the last, its high-conviction idea is to keep buying airlines, such as Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), and United Continental (UAL). Elsewhere in Transports, Wald is bullish on the breakout in shares of FedEx (FDX) and Old Dominion (ODFL), and views Norfolk Southern (NSC) and Landstar System (LSTR) as attractive pre-breakout candidates.
09/21/17
UBSW
09/21/17
NO CHANGE
UBSW
Recent correction in airline stocks overdone, says UBS
UBS analyst Darryl Genovesi noted that United Continental (UAL) and Alaska Air (ALK) are down about 20% while Delta (DAL) and American (AAL) have fallen about 10% so far in Q3 as the fare-matching narrative has re-surfaced and estimates for fuel costs have risen. However, he views the recent correction as overdone and thinks the airline group as a whole, which was cheap before, is cheaper now without the forward earnings growth outlook being any worse. Genovesi, who doesn't see evidence of a demand drop off in the travel agency data he tracks, thinks Q3 RASM weakness is predominantly "self-inflicted" by oversupply. Other publicly traded companies in the space include JetBlue (JBLU) and Southwest (LUV).
09/25/17
MACQ
09/25/17
INITIATION
Target $94
MACQ
Outperform
Alaska Air initiated with an Outperform at Macquarie
Macquarie analyst Susan Donofrio initiated Alaska Air with an Outperform and $94 price target. The analyst believes shares will outperform due to balance sheet strength and new revenue growth opportunities from the merger with Virgin America. Donofrio also expects cost initiatives will mitigate the impact from higher wage costs and for shares to benefit from management's focus on shareholder value.
DXJ WisdomTree Japan Hedged Equity Fund

TBT ProShares UltraShort 20+ yr Trsry

BBRY BlackBerry
$9.23

0.09 (0.98%)

08/07/17
08/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. XPO Logistics (XPO) resumed with an Outperform at William Blair. 2. BlackBerry (BBRY) reinstated with a Sell at Goldman Sachs. 3. Brighthouse Financial (BHF) was initiated with a Sell at Citi, a Market Perform at Keefe Bruyette, FBR Capital, and Wells Fargo, a Sector Perform at RBC Capital, and a Neutral at Credit Suisse. 4. Zoetis (ZTS) reinstated with a Neutral at Goldman Sachs. 5. BeiGene (BGNE) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/17
BOFA
09/22/17
NO CHANGE
Target $8
BOFA
Underperform
BlackBerry valuation unattractive, says BofA/Merrill
BofA/Merrill analyst Daniel Bartus continues to view BlackBerry's valuation as unattractive saying the company has a long path to profitability, the Enterprise segment valuation is too high, QNX is low growth and at risk of share loss near-term, and Q1 software/services growth was due to a shift from handset related revenues. The analyst raised his price target on BlackBerry to $8 from 7.50 and maintained an Underperform rating on shares.
09/22/17
RBCM
09/22/17
NO CHANGE
Target $9.5
RBCM
Sector Perform
BlackBerry can use $1.6B of cash on acquisitions, says RBC Capital
RBC Capital analyst Paul Treiber says BlackBerry (BBRY) has $2.36B in cash after the $940M award from Qualcomm (QCOM). The company can use up to $1.6B of the cash on acquisitions, which may be accretive to earnings and the stock price, Treiber tells investors in a research note. He fells an acquisition of a company with organic growth above BlackBerry's targeted 10%-15% software growth "would be a tailwind to BlackBerry's organic growth." Treiber expects in-line Q2 results from BlackBerry on September 28 and keeps a Sector Perform rating on the shares.
08/11/17
ADAM
08/11/17
NO CHANGE
Target $10
ADAM
Hold
BlackBerry equipped to invest for growth, says Canaccord
Canaccord analyst T. Michael Walkley said Blackberry management gave an upbeat presentation at the firm's conference and explained how the company has completed its transformation into an enterprise software and services company. The analyst noted the company's strong balance sheet, including its cash balance, lead him to believe they have the capital to invest for growth by both hiring and through acquisition. Walkley maintained his Hold rating and $10 price target on Blackberry shares.
WFT Weatherford

07/06/17
BERN
07/06/17
DOWNGRADE
BERN
Market Perform
Weatherford downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Colin Davies downgraded Weatherford based on his belief that global investment in energy exploration and production will slow tremendously next year, falling about 2% globally and rising just 2% in the U.S. He says that E&Ps will have to reduce their rig count next year. Target to $5 from $7.
07/06/17
BERN
07/06/17
NO CHANGE
BERN
'Global E&P investment to stall in 2018, ' says Bernstein
Bernstein analyst Colin Davies says that global investment in energy exploration and production will slow tremendously next year, falling about 2% globally and rising just 2% in the U.S. He says that E&Ps will have to reduce their rig count next year. In conjunction with the note, the analyst downgraded Noble Corp. (NE) to Underperform from Market Perform, downgraded Transocean (RIG) to Market Perform from Outperform, and downgraded Weatherford (WFT) to Market Perform from Outperform. He upgraded Schlumberger (SLB) to Outperform from Market Perform. Price target on Noble Corp to $2.50 from $7, on Transocean to $9 from $16.50, on Weatherford to $5 from $7, and on Schlumberger to $80 from $94.
08/03/17
BMOC
08/03/17
NO CHANGE
BMOC
Weatherford price target to $5.50 from $4.75 at BMO Capital
After meeting with Weatherford's new CEO, BMO Capital analyst Daniel Boyd says he can raise the company's EBITDA by 50% even if oil prices stay flat "by eliminating half of the support cost gap with peers." The analyst raised his price target on the stock to $5.50 from $4.75 and keeps an Outperform rating.
07/31/17
RHCO
07/31/17
NO CHANGE
RHCO
Weatherford reported 'solid' Q2 results, says SunTrust
SunTrust analyst Ken Sill says that Weatherford reported "solid" Q2 results, as its EPS beat expectations, excluding an accounting charge related to Venezuela. He says that the company's cost cutting is boosting its bottom line, and he keeps an $8 price target and a Buy rating on the shares.
OIH Oil Services Holders Trust

WFC Wells Fargo

09/28/17
NOMU
09/28/17
DOWNGRADE
NOMU
Neutral
U.S. Bancorp downgraded to Neutral from Buy at Nomura Instinet
Nomura Instinet analyst Bill Carcache downgraded U.S. Bancorp (USB) to Neutral saying he sees downside risk to net interest income and provision expectations. Consensus expects U.S. Bancorp's loan growth to accelerate to 6% by 2018, which is too optimistic given the bank's recent comments, the analyst contends. He lowered his price target for the shares to $55 from $57. Carcache remains bullish on Wells Fargo (WFC) and raised his price target for the shares to $65 from $64.
09/26/17
DBAB
09/26/17
DOWNGRADE
Target $136
DBAB
Hold
PNC Financial downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O'Connor downgraded PNC Financial (PNC) to Hold as he seeks to lessen exposure to traditional banks. The analyst sees net interest income growth slowing and credit costs inching up as the Fed raises short rates and the yield curve flattens. He believes a number of positives are priced into PNC shares. O'Connor upped his price target for the stock to $136 from $130. The analyst continues to prefer banks with a "turnaround angle," like Goldman Sachs (GS) and Wells Fargo (WFC), and remains positive on capital markets businesses like Morgan Stanley (MS). O'Connor this morning also downgraded JPMorgan (JPM) to Hold.
09/15/17
UBSW
09/15/17
NO CHANGE
Target $56
UBSW
Neutral
Wells Fargo revenue headwinds can persist, says UBS
UBS analyst Saul Martinez said proprietary analysis suggests Wells Fargo's difficult backdrop for client acquisition remains and the recent disclosures have kept the company in the spotlight for the wrong reasons. He believes earnings growth depends on efficiency improvement and more aggressive stock buybacks. Martinez maintained his Neutral rating and lowered his price target to $56 from $59 on Wells Fargo shares.
09/14/17
SBSH
09/14/17
NO CHANGE
SBSH
Buy
Citi says business model not broken, time to buy Wells Fargo
Citi analyst Keith Horowitz proclaims now is the time to buy shares of Wells Fargo. Over the past year, the company's total return is up 7% versus 36% for peers, Horowitz tells investors in a research note. He attributes all the underperformance to lower multiple expansion. Wells now trades at the highest implied cost of equity at 10.9% on the analyst's valuation screen, which he says has historically been a very good buy indicator. Horowitz believes Wells Fargo's business improved, not broken. The company's issue is an "aggressive sales culture encouraged the wrong behavior leading to strong account generation," which had an immaterial impact to earnings, Horowitz writes. He believes the bank's fundamental outlook has not changed.
RIG Transocean

09/25/17
09/25/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Buy from Hold at Deutsche Bank with analyst Rod Lache saying GM's autonomous vehicles will be ready for commercial deployment, without human drivers, much sooner than widely expected and possibly years ahead of competitors. 2. Ross Stores (ROST) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss saying he left meetings with management more positive on the off-price sector and believes the company is well positioned for double-digit growth. 3. Under Armour (UA, UAA) upgraded to Overweight from Sector Weight at KeyBanc with analyst Edward Yruma saying the addition of a new chief operating officer along with a renewed focus on improving financial performance point to a near-term inflection for the shares. 4. Transocean (RIG) upgraded to Buy from Neutral at UBS with analyst Angie Sedita citing "early signs of a slow recovery." 5. Box (BOX) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Peterson saying risk/reward is compelling at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/01/17
CLKS
09/01/17
UPGRADE
CLKS
Buy
Transocean upgraded to Buy from Neutral at Clarksons Platou
09/25/17
UBSW
09/25/17
UPGRADE
UBSW
Buy
Transocean upgraded to Buy from Neutral at UBS
UBS analyst Angie Sedita upgraded Transocean and other offshore drillers to Buy citing "early signs of a slow recovery." The analyst believes a bottom has been reached in offshore utilization for both floaters and jackups and that demand will slowly move higher in 2018. She views current valuations in the space as compelling and raised her price target for Transocean shares to $15 from $9.
08/31/17
08/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. FMC Corporation (FMC) upgraded to Buy from Underperform at BofA/Merrill with analyst Steve Byrne double upgrading FMC following survey results that indicate ag sales are likely to increase 1-3% rather than decline 1-3%, as previously expected. 2. Owens Corning (OC) upgraded to Outperform from Market Perform at Wells Fargo with analyst Stephen East saying he sees an "inexpensive valuation" versus peers and has increased comfort in Owens' ability to achieve or surpass this year's targets. Hurricane Harvey is a boost to the company's roofing business, but its insulation replacement "may be the bigger winner," East tells investors. 3. ChannelAdvisor (ECOM) upgraded to Overweight from Equal-Weight at First Analysis with analyst Lawrence Berlin citing increased confidence in the company's ability to accelerate growth and hit its mid-teen growth targets after meeting with management. 4. Abercrombie & Fitch (ANF) upgraded to Sector Perform from Underperform at RBC Capital with analyst Brian Tunick saying a return to profitability in the second half of 2017 is more likely following Q2 results that suggest that turnaround efforts are yielding results faster than anticipated. 5. Transocean (RIG) upgraded to Overweight from Equalweight at Capital One with analyst Joseph Gibney saying the group is exhibiting some modest "green shoots" and sees upside to Transocean on a relative basis even in a long/measured recovery and some semblance of contracting pickup. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

, SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

16:57
10/22/17
10/22
16:57
10/22/17
16:57
Conference/Events
Sun Bancorp to host special shareholder meeting »

Special Shareholder…

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 27

    Oct

  • 15

    Nov

SGU

Star Gas Partners, L.P.

$10.52

-0.16 (-1.50%)

16:49
10/22/17
10/22
16:49
10/22/17
16:49
Conference/Events
Star Gas Partners, L.P. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ETRM

EnteroMedics

$2.05

0.07 (3.54%)

16:44
10/22/17
10/22
16:44
10/22/17
16:44
Conference/Events
EnteroMedics to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

, SSB

South State

$92.15

-0.2 (-0.22%)

16:39
10/22/17
10/22
16:39
10/22/17
16:39
Conference/Events
South State to host special shareholder meeting »

Special Shareholder…

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

SSB

South State

$92.15

-0.2 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

SSB

South State

$92.15

-0.2 (-0.22%)

, PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

16:36
10/22/17
10/22
16:36
10/22/17
16:36
Conference/Events
Park Sterling Bank to host special shareholder meeting »

Special Shareholder…

SSB

South State

$92.15

-0.2 (-0.22%)

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

, CARO

Carolina Financial

$36.17

0.23 (0.64%)

16:22
10/22/17
10/22
16:22
10/22/17
16:22
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

CARO

Carolina Financial

$36.17

0.23 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CARO

Carolina Financial

$36.17

0.23 (0.64%)

, FSBK

First South Bancorp

$18.66

0.14 (0.76%)

16:19
10/22/17
10/22
16:19
10/22/17
16:19
Conference/Events
First South Bancorp to host special shareholder meeting »

Special Shareholder…

CARO

Carolina Financial

$36.17

0.23 (0.64%)

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

13:41
10/22/17
10/22
13:41
10/22/17
13:41
Periodicals
Fox knew of new harassment settlement before signing O'Reilly, Reuters says »

Forced to resign in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TM

Toyota

$123.71

0.64 (0.52%)

13:37
10/22/17
10/22
13:37
10/22/17
13:37
Periodicals
Toyota to halt operations at Japan plants as typhoon approaches, Reuters says »

Toyota is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

, BAC

Bank of America

$27.17

0.59 (2.22%)

13:34
10/22/17
10/22
13:34
10/22/17
13:34
Hot Stocks
IntercontinentalExchange completes BofA Merrill's Index Platform acquisition »

Intercontinental Exchange…

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

BAC

Bank of America

$27.17

0.59 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

VCYT

Veracyte

$9.30

0.11 (1.20%)

13:30
10/22/17
10/22
13:30
10/22/17
13:30
Hot Stocks
Veracyte announces new data, highlights Afirma GSC performance »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$63.88

0.13 (0.20%)

13:19
10/22/17
10/22
13:19
10/22/17
13:19
Hot Stocks
Study shows Merck Zepatier resulted in high sustained virologic response rates »

Merck has announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

  • 02

    Feb

EADSY

Airbus

$23.76

-0.135 (-0.56%)

, BDRBF

Bombardier

$2.25

0.04 (1.81%)

12:57
10/22/17
10/22
12:57
10/22/17
12:57
Periodicals
Airbus turmoil overshadows bid to rescue Bombardier CSeries, Reuters says »

Airbus's (EADSY)…

EADSY

Airbus

$23.76

-0.135 (-0.56%)

BDRBF

Bombardier

$2.25

0.04 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

, SPX

S&P 500

11:19
10/22/17
10/22
11:19
10/22/17
11:19
Periodicals
Senate Republican Leader says tax bill to be revenue neutral, Reuters reports »

Mitch McConnell said he…

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$15.56

0.31 (2.03%)

11:15
10/22/17
10/22
11:15
10/22/17
11:15
Periodicals
People use Snapchat at parties, not as much at sports stadiums, Recode says »

There seems to be a huge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

TSLA

Tesla

$345.10

-6.71 (-1.91%)

11:09
10/22/17
10/22
11:09
10/22/17
11:09
Periodicals
Tesla reaches deal for Shanghai manufacturing facility, WSJ reports »

Tesla has reached an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

, UNH

UnitedHealth

$207.49

4.24 (2.09%)

11:01
10/22/17
10/22
11:01
10/22/17
11:01
Periodicals
Senator McConnell waiting for Trump's OK on healthcare bill, Reuters says »

Republican Senate Leader…

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

CNC

Centene

$96.50

1.8 (1.90%)

WCG

WellCare

$180.52

3.28 (1.85%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

AET

Aetna

$160.84

3.2 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

TSLA

Tesla

$345.10

-6.71 (-1.91%)

10:57
10/22/17
10/22
10:57
10/22/17
10:57
Periodicals
Tesla expects to agree on deal to build cars in China by year-end, Reuters says »

Tesla is talking with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.